Torsten Keßler

3.0k citations

92 papers · 2.1k indexed · h-index 26

Impact in

Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research

Papers in ⓘ

Hematology 31
- Acute Myeloid Leukemia Research 22
Immunology and Allergy 12
- Cell Adhesion Molecules Research 12

Co-authors: Wolfgang E. Berdel (60 shared papers)Rolf M. Mesters (48 shared papers)Ralf Bieker (16 shared papers)Teresa Padró (11 shared papers)Christoph Schliemann (34 shared papers)David A. Cheresh (4 shared papers)Christian Schwöppe (20 shared papers)Steve Silletti (4 shared papers)
Journals: Blood (9 papers)Annals of Hematology (5 papers)PLoS ONE (4 papers)Leukemia (3 papers)European Journal of Cancer (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Torsten Keßler

89 papers receiving 2.1k citations

Peers

Countries citing papers authored by Torsten Keßler

Since Specialization

Citations

This map shows the geographic impact of Torsten Keßler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Keßler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Keßler more than expected).

Fields of papers citing papers by Torsten Keßler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Keßler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Keßler. The network helps show where Torsten Keßler may publish in the future.

Co-authors

The 25 scholars most cited alongside Torsten Keßler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Torsten Keßler Line = papers co-authored together Torsten Keßler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia Leukemia ·Teresa Padró, Ralf Bieker, Sandra Ruíz, Martin Steins, S. Retzlaff, Horst Bürger, Thomas Büchner, Torsten Keßler, Federico Herrera, Joachim Kienast, Carsten Müller‐Tidow, Hubert Serve, W. E. Berdel, RM Mesters	2002	173
2	Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2 Proceedings of the National Academy of Sciences ·Alexander Pfeifer, Torsten Keßler, Steve Silletti, David A. Cheresh, Inder M. Verma	2000	119
3	Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience Blood ·Ralf Bieker, Torsten Keßler, Christian Schwöppe, Teresa Padró, Thorsten Persigehl, Christoph Bremer, Johannes Dreischalück, A. Kolkmeyer, Walter Heindel, Rolf M. Mesters, Wolfgang E. Berdel	2009	118
4	Transduction of Liver Cells by Lentiviral Vectors: Analysis in Living Animals by Fluorescence Imaging Molecular Therapy ·Alexander Pfeifer, Torsten Keßler, Meng Yang, Eugene Baranov, Neeltje A. Kootstra, David A. Cheresh, Robert M. Hoffman, Inder M. Verma	2001	93
5	Efficacy and safety of thalidomide in patients with acute myeloid leukemia Blood ·Martin Steins, Teresa Padró, Ralf Bieker, Sandra Ruíz, Martin Kropff, Joachim Kienast, Torsten Keßler, Thomas Buechner, Wolfgang E. Berdel, Rolf M. Mesters	2002	78
6	Inhibition of Tumor Growth by RGD Peptide–Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature Clinical Cancer Research ·Torsten Keßler, Ralf Bieker, Teresa Padró, Christian Schwöppe, Thorsten Persigehl, Christoph Bremer, Michael Kreuter, Wolfgang E. Berdel, Rolf M. Mesters	2005	70
7	Angiogenesis Inhibition in Cancer Therapy Recent results in cancer research ·Iris Appelmann, Rüediger Liersch, Torsten Keßler, Rolf M. Mesters, Wolfgang E. Berdel	2009	58
8	Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. PubMed ·Ralf Bieker, Teresa Padró, Julia Krämer, Martin Steins, Torsten Keßler, Stephan Retzlaff, Federico Herrera, Joachim Kienast, Wolfgang E. Berdel, Rolf M. Mesters	2003	56
9	Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia. PubMed ·Christoph Schliemann, Ralf Bieker, Teresa Padró, Torsten Keßler, Heike Hintelmann, Thomas Büchner, Wolfgang E. Berdel, Rolf M. Mesters	2006	56
10	Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis Oncology Letters ·Michael Möhr, Christoph Schliemann, Christoph Biermann, Lars‐Henning Schmidt, Torsten Keßler, Joachim Schmidt, Karsten Wiebe, Klaus‐Michael Müller, Thomas K. Hoffmann, Andreas H. Groll, Claudius Werner, Christina Keßler, Rainer Wiewrodt, Claudia Rudack, Wolfgang E. Berdel	2014	53
11	Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients Blood ·Rüediger Liersch, Joachim Gerß, Christoph Schliemann, Michael Bayer, Christian Schwöppe, Christoph Biermann, Iris Appelmann, Torsten Keßler, Bob Löwenberg, Thomas Büchner, Wolfgang Hiddemann, Carsten Müller‐Tidow, Wolfgang E. Berdel, Rolf M. Mesters	2012	52
12	Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy – a longitudinal study Leukemia ·Andrea Schumacher, Torsten Keßler, Thomas Büchner, Donavon Wewers, J. van de Loo	1998	49
13	Antiangiogenic Tumor Treatment: Early Noninvasive Monitoring with USPIO-enhanced MR Imaging in Mice Radiology ·Thorsten Persigehl, Ralf Bieker, Lars Matuszewski, Alexander Wall, Torsten Keßler, Hendrik Kooijman, Norbert Meier, Wolfgang Ebert, Wolfgang E. Berdel, Walter Heindel, Rolf M. Mesters, Christoph Bremer	2007	49
14	Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia Leukemia ·Christoph Schliemann, Ralf Bieker, Nils H. Thoennissen, (unknown), Rüediger Liersch, Torsten Keßler, Thomas Büchner, Wolfgang E. Berdel, Rolf M. Mesters	2007	48
15	Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects British Journal Of Nutrition ·Torsten Keßler, Albrecht Hesse	2000	47
16	Identification of a Novel Class of Small-Molecule Antiangiogenic Agents through the Screening of Combinatorial Libraries Which Function by Inhibiting the Binding and Localization of Proteinase MMP2 to Integrin α_Vβ₃ Journal of the American Chemical Society ·Dale L. Boger, Joel Goldberg, Steve Silletti, Torsten Keßler, David A. Cheresh	2001	46
17	Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization British Journal Of Nutrition ·Ruth Hönow, Norbert Laube, Anke Schneider, Torsten Keßler, Albrecht Hesse	2003	43
18	Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies Current Drug Targets ·Torsten Keßler, Frauke Fehrmann, Ralf Bieker, Wolfgang E. Berdel, Rolf M. Mesters	2007	42
19	Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation Cancer Immunology Research ·Christoph Schliemann, Katrin L. Gutbrodt, Andrea Kerkhoff, Michele Pohlen, Stefanie Wiebe, Gerda Silling, Linus Angenendt, Torsten Keßler, Rolf M. Mesters, Leonardo Giovannoni, Michael Schäfers, Bianca Altvater, Claudia Rössig, Inga Grünewald, Eva Wardelmann, Gabriele Köhler, Dario Neri, Matthias Stelljes, Wolfgang E. Berdel	2015	38
20	Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing’s sarcoma European Journal of Cancer ·Michael Kreuter, Michael Paulussen, Johannes Boeckeler, Joachim Gerß, Horst Buerger, Caren Liebscher, Torsten Keßler, Heribert Jürgens, Wolfgang E. Berdel, Rolf M. Mesters	2006	37

About Torsten Keßler

Torsten Keßler is a scholar working on Hematology, Immunology and Allergy, Oncology, Cancer Research and Genetics, having authored 92 papers that have together received 2.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Peptidase Inhibition and Analysis (17 papers), Angiogenesis and VEGF in Cancer (13 papers), Cell Adhesion Molecules Research (12 papers), Sarcoma Diagnosis and Treatment (12 papers), Protease and Inhibitor Mechanisms (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (529 citations), Immunology and Allergy (157 citations), Oncology (685 citations), Cancer Research (341 citations) and Genetics (178 citations). Torsten Keßler has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wolfgang E. Berdel, Rolf M. Mesters, Ralf Bieker, Teresa Padró, Christoph Schliemann, David A. Cheresh, Christian Schwöppe, Steve Silletti, Inder M. Verma and Alexander Pfeifer. Their work appears in journals such as Blood, Annals of Hematology, PLoS ONE, Leukemia and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact